Foghorn Therapeutics Inc. (FHTX) Return on equity 2020–2022
Foghorn Therapeutics Inc. (FHTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-97216.1%FY2022 · since FY2020: -47.1% → -97216.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -97216.1% | -97111.5 pp |
| FY2021 | -104.6% | -57.5 pp |
| FY2020 | -47.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More FHTX financial trends
FHTX RevenueFHTX Net incomeFHTX Net marginFHTX Gross profitFHTX Gross marginFHTX Operating incomeFHTX Operating marginFHTX Operating cash flowFHTX Free cash flowFHTX Capital expendituresFHTX Stock buybacksFHTX Dividends paidFHTX Total assetsFHTX Total liabilitiesFHTX Shareholders’ equityFHTX overview →